Search
for
Sort by
Research 601–630 of 1000+
- Ferulic acid promotes hair growth via estrogen receptor alpha activation in cultured human dermal papilla cells
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Pharmacotherapy of alopecia areata
- Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Healing hair naturally: A case study of alopecia areata treated with individualized homeopathy
- Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib
- Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
- Journal of Population Therapeutics and Clinical Pharmacology
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Alopecia Areata and Vitamin D3 Deficiency: The Potential of Calcipotriol as a Treatment
- Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Causal Relationship and Potential Common Pathogenic Mechanisms Between Alopecia Areata and Related Cancer
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Effect of diode pumping solid state laser with wavelength 589 nm on gene expression of interlukine-2 and interferon-gamma Lowercase in human T-lymphocytes
- Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Unique Treatment for Alopecia Areata Combining Epinephrine With an Intralesional Steroid
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- Analysis of histology and long noncoding RNAs involved in the rabbit hair follicle density using RNA sequencing
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- Alopecia Totalis Treated with 1064 nm Picosecond Nd:YAG Laser: A Case Report